These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 31379147)

  • 1. Comparative analysis of a panel of biomarkers related to protein phosphatase 2A between laryngeal squamous cell carcinoma tissues and adjacent normal tissues.
    Wang HY; Yuan H; Liu JH; Wang BL; Xu KL; Huang P; Lin ZH; Xu LH
    J Zhejiang Univ Sci B; 2019 Sept.; 20(9):776-780. PubMed ID: 31379147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PAQR3 plays a suppressive role in laryngeal squamous cell carcinoma.
    Wu Q; Zhuang K; Li H
    Tumour Biol; 2016 Jan; 37(1):561-5. PubMed ID: 26232324
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CIP2A inhibits PP2A in human malignancies.
    Junttila MR; Puustinen P; Niemelä M; Ahola R; Arnold H; Böttzauw T; Ala-aho R; Nielsen C; Ivaska J; Taya Y; Lu SL; Lin S; Chan EK; Wang XJ; Grènman R; Kast J; Kallunki T; Sears R; Kähäri VM; Westermarck J
    Cell; 2007 Jul; 130(1):51-62. PubMed ID: 17632056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncogenic nexus of cancerous inhibitor of protein phosphatase 2A (CIP2A): an oncoprotein with many hands.
    De P; Carlson J; Leyland-Jones B; Dey N
    Oncotarget; 2014 Jul; 5(13):4581-602. PubMed ID: 25015035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CIP2A mediates effects of bortezomib on phospho-Akt and apoptosis in hepatocellular carcinoma cells.
    Chen KF; Liu CY; Lin YC; Yu HC; Liu TH; Hou DR; Chen PJ; Cheng AL
    Oncogene; 2010 Nov; 29(47):6257-66. PubMed ID: 20729919
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CIP2A-mediated Akt activation plays a role in bortezomib-induced apoptosis in head and neck squamous cell carcinoma cells.
    Lin YC; Chen KC; Chen CC; Cheng AL; Chen KF
    Oral Oncol; 2012 Jul; 48(7):585-93. PubMed ID: 22342571
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HMGA1 and ezrin in laryngeal squamous cell carcinoma.
    Wang DS; Pan CC; Lai HC; Huang JM
    Acta Otolaryngol; 2013 Jun; 133(6):626-32. PubMed ID: 23394223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CIP2A, an oncoprotein, is associated with cell proliferation, invasion and migration in laryngeal carcinoma cells.
    Chen XD; Tang SX; Zhang JH; Zhang LT; Wang YW
    Oncol Rep; 2017 Aug; 38(2):1005-1012. PubMed ID: 28656258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.
    de Barros E Lima Bueno R; Ramão A; Pinheiro DG; Alves CP; Kannen V; Jungbluth AA; de Araújo LF; Muys BR; Fonseca AS; Plaça JR; Panepucci RA; Neder L; Saggioro FP; Mamede RC; Figueiredo DL; Silva WA
    Tumour Biol; 2016 Nov; 37(11):15087-15096. PubMed ID: 27658780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erlotinib derivative inhibits hepatocellular carcinoma by targeting CIP2A to reactivate protein phosphatase 2A.
    Yu HC; Hung MH; Chen YL; Chu PY; Wang CY; Chao TT; Liu CY; Shiau CW; Chen KF
    Cell Death Dis; 2014 Jul; 5(7):e1359. PubMed ID: 25077545
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene expression profiling via bioinformatics analysis reveals biomarkers in laryngeal squamous cell carcinoma.
    Guan GF; Zheng Y; Wen LJ; Zhang DJ; Yu DJ; Lu YQ; Zhao Y; Zhang H
    Mol Med Rep; 2015 Aug; 12(2):2457-64. PubMed ID: 25936657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of mRNA Expression Levels of LRP1 and Actin-Binding Proteins with the Development of Laryngeal and Laryngopharyngeal Squamous Cell Carcinoma.
    Kakurina GV; Kolegova ЕS; Shashova ЕЕ; Velikaya VV; Startseva ZА; Cheremisina ОV; Kondakova IV; Choinzonov ЕL
    Bull Exp Biol Med; 2020 Oct; 169(6):802-805. PubMed ID: 33108559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
    Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
    Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of MMP1 and MMP2 by RNA-seq analysis in laryngeal squamous cell carcinoma.
    Fang W; Shen J
    Am J Otolaryngol; 2020; 41(3):102391. PubMed ID: 31932027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basement membrane protein ladinin-1 and the MIF-CD44-β1 integrin signaling axis are implicated in laryngeal cancer metastasis.
    Klobučar M; Sedić M; Gehrig P; Grossmann J; Bilić M; Kovač-Bilić L; Pavelić K; Kraljević Pavelić S
    Biochim Biophys Acta; 2016 Oct; 1862(10):1938-54. PubMed ID: 27460703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.
    Liu CY; Huang TT; Chen YT; Chen JL; Chu PY; Huang CT; Wang WL; Lau KY; Dai MS; Shiau CW; Tseng LM
    EBioMedicine; 2019 Feb; 40():263-275. PubMed ID: 30651219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical expression of p27(kip1) in metastatic laryngeal squamous cell carcinoma.
    Bodnar M; Szylberg Ł; Kaźmierczak W; Marszałek A
    Adv Med Sci; 2014 Sep; 59(2):206-12. PubMed ID: 25323759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SLC7A11, a component of cysteine/glutamate transporter, is a novel biomarker for the diagnosis and prognosis in laryngeal squamous cell carcinoma.
    Ma Z; Zhang H; Lian M; Yue C; Dong G; Jin Y; Li R; Wan H; Wang R; Wang Y; Zhai J; Ma H; Feng L; Han J; Liu S; Guo Y; Li J; Liu Y; Fang J; Liu H
    Oncol Rep; 2017 Nov; 38(5):3019-3029. PubMed ID: 29048627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The expression and clinical significance of RhoA, Ezrin and CD44 in laryngeal squamous cell carcinoma].
    Xie YX; Shang XL; Fan J
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Feb; 31(3):191-194. PubMed ID: 29871220
    [No Abstract]   [Full Text] [Related]  

  • 20. Cancerous inhibitor of protein phosphatase 2A, an emerging human oncoprotein and a potential cancer therapy target.
    Khanna A; Pimanda JE; Westermarck J
    Cancer Res; 2013 Nov; 73(22):6548-53. PubMed ID: 24204027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.